Avedro (AVDR) began trading on the Nasdaq on 14 February 2019

Avedro, Inc., an ophthalmic pharmaceutical and medical device company, develops and commercializes products to treat ophthalmic disorders and conditions, primarily associated with corneal weakness.

• Sector: Healthcare
• Industry: Medical Devices
• HQ: Waltham, Massachusetts
• http://avedro.com